McDade H - Search Results

1

Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.

Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M. Gori A, et al. Among authors: mcdade h. Antivir Ther. 2004 Aug;9(4):603-14. Antivir Ther. 2004. PMID: 15456092 Clinical Trial.

2

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.

Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W, Schuwirth CM, Kauffmann RH, Meenhorst PL, McDade H, Goodwin C, Leonard JM, Goudsmit J, Danner SA. Notermans DW, et al. Among authors: mcdade h. AIDS. 1998 Jan 22;12(2):167-73. doi: 10.1097/00002030-199802000-00006. AIDS. 1998. PMID: 9468365 Clinical Trial.

3

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

Bart PA, Rizzardi GP, Tambussi G, Chave JP, Chapuis AG, Graziosi C, Corpataux JM, Halkic N, Meuwly JY, Munoz M, Meylan P, Spreen W, McDade H, Yerly S, Perrin L, Lazzarin A, Pantaleo G. Bart PA, et al. Among authors: mcdade h. AIDS. 2000 Sep 8;14(13):1887-97. doi: 10.1097/00002030-200009080-00002. AIDS. 2000. PMID: 10997391 Clinical Trial.

4

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection.

Andersson J, Kinloch S, Sönnerborg A, Nilsson J, Fehniger TE, Spetz AL, Behbahani H, Goh LE, McDade H, Gazzard B, Stellbrink H, Cooper D, Perrin L. Andersson J, et al. Among authors: mcdade h. J Infect Dis. 2002 May 1;185(9):1355-8. doi: 10.1086/340124. Epub 2002 Apr 16. J Infect Dis. 2002. PMID: 12001057

5

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.

Zhang ZQ, Notermans DW, Sedgewick G, Cavert W, Wietgrefe S, Zupancic M, Gebhard K, Henry K, Boies L, Chen Z, Jenkins M, Mills R, McDade H, Goodwin C, Schuwirth CM, Danner SA, Haase AT. Zhang ZQ, et al. Among authors: mcdade h. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1154-9. doi: 10.1073/pnas.95.3.1154. Proc Natl Acad Sci U S A. 1998. PMID: 9448301 Free PMC article.

6

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Schuwirth CM, Goudsmit J, Danner SA, Haase AT. Cavert W, et al. Among authors: mcdade h. Science. 1997 May 9;276(5314):960-4. doi: 10.1126/science.276.5314.960. Science. 1997. PMID: 9139661 Clinical Trial.

7

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

Staszewski S, Loveday C, Picazo JJ, Dellarnonica P, Skinhøj P, Johnson MA, Danner SA, Harrigan PR, Hill AM, Verity L, McDade H. Staszewski S, et al. Among authors: mcdade h. JAMA. 1996 Jul 10;276(2):111-7. JAMA. 1996. PMID: 8656502 Clinical Trial.

8

Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.

Staszewski S, Hill AM, Bartlett J, Eron JJ, Katlama C, Johnson J, Sawyer W, McDade H. Staszewski S, et al. Among authors: mcdade h. AIDS. 1997 Mar 15;11(4):477-83. doi: 10.1097/00002030-199704000-00011. AIDS. 1997. PMID: 9084795 Clinical Trial.

9

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study.

van Leeuwen R, Katlama C, Kitchen V, Boucher CA, Tubiana R, McBride M, Ingrand D, Weber J, Hill A, McDade H, et al. van Leeuwen R, et al. Among authors: mcdade h. J Infect Dis. 1995 May;171(5):1166-71. doi: 10.1093/infdis/171.5.1166. J Infect Dis. 1995. PMID: 7751691 Clinical Trial.

10

Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection.

Loré K, Sönnerborg A, Broström C, Goh LE, Perrin L, McDade H, Stellbrink HJ, Gazzard B, Weber R, Napolitano LA, van Kooyk Y, Andersson J. Loré K, et al. Among authors: mcdade h. AIDS. 2002 Mar 29;16(5):683-92. doi: 10.1097/00002030-200203290-00003. AIDS. 2002. PMID: 11964524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters